Sol-Gel Technologies (SLGL) Return on Sales (2018 - 2026)

Sol-Gel Technologies' (SLGL) quarterly Return on Sales came in at 0.36% in Q1 2026, up 27.0% year-on-year from 0.28% in Q1 2025, and up 140.12% on a QoQ basis from 0.89% in Q4 2025.

Sol-Gel Technologies (SLGL) Return on Sales (2018 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 9 years of Return on Sales data on file, last reported at 0.36% in Q1 2026.

  • On a quarterly basis, Return on Sales rose 27.0% year-over-year to 0.36% in Q1 2026; TTM through Mar 2026 was 0.03%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.03%, up 2.0% from the prior year.
  • Return on Sales for Q1 2026 stood at 0.36%, up from 0.89% in the prior quarter.
  • Over the last five years, Return on Sales for SLGL reached as high as 0.36% in Q1 2026 and fell as low as 5.09% in Q4 2022.
  • Historically, Return on Sales has averaged 0.63% across 5 years, with a median of 0.11% in 2023.
  • Across the five-year window, Return on Sales tumbled 510 bps in 2022 and jumped 390 bps in 2023, its largest moves.
  • Year by year, Return on Sales stood at 5.09% in 2022, then surged by 77 bps to 1.19% in 2023, then slumped by 69 bps to 2.01% in 2024, then surged by 56 bps to 0.89% in 2025, then jumped by 140 bps to 0.36% in 2026.
  • Per Business Quant data, the three most recent Return on Sales figures were 0.36% in Q1 2026, 0.89% in Q4 2025, and 0.16% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn - 0.36%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.36%
Dec 31, 2025 -0.89%
Sep 30, 2025 -0.16%
Jun 30, 2025 0.01%
Mar 31, 2025 0.09%
Dec 31, 2024 -2.01%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Dec 31, 2023 -1.19%
Sep 30, 2023 -0.30%
Jun 30, 2023 -0.11%
Dec 31, 2022 -5.09%
Sep 30, 2022 -0.14%
Jun 30, 2022 0.00%
Mar 31, 2022 0.00%
Dec 31, 2021 0.01%
Sep 30, 2021 0.01%
Jun 30, 2021 0.09%
Mar 31, 2021 0.06%
Dec 31, 2020 -0.03%